Benzimidazole derivatives and their use as protein kinases inhibitors

Details for Australian Patent Application No. 2004253338 (hide)

International Classifications

Event Publications

22 December 2005 PCT application entered the National Phase

PCT publication WO2005/002552 Priority application(s): WO2005/002552

2 February 2006 Change of Name(s) of Applicant(s), Section 104

Astex Technology Limited The name of the applicant has been changed to Astex Therapuetics Limited

16 February 2006 Corrigenda

Change of Names(s) of Applicant(s), Section 104 - 2004 Under the name Astex Therapuetics Limited, Application No. 2004253338 correct the name the read Astex Therapeutics Limited Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002231318 S.C. Johnson & Son, Inc. 2002315907 Canon Kabushiki Kaisha 2002324582 Schering Corporation

18 February 2010 Application Accepted

Published as AU-B-2004253338

17 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.